𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Osteoinduction by microbubble-enhanced transcutaneous sonoporation of human bone morphogenetic protein-2

✍ Scribed by Kenji Osawa; Yasunori Okubo; Kazumasa Nakao; Noriaki Koyama; Kazuhisa Bessho

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
419 KB
Volume
11
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Bone morphogenetic protein‐2 (BMP‐2) is believed to participate in bone healing and regeneration. Previous studies using BMP‐2 in clinical applications have encountered difficulties that include the lack of an efficient, safe and simple delivery system, and expensive proteins and matrices. The gene transfer approach is a promising option for utilizing BMP‐2. Viral vector‐mediated gene transfer is efficient, but safety concerns prevent its clinical application for common diseases. Sonoporation is a simple and inexpensive method that only requires a plasmid and a sonoporation device.

Methods

We used a plasmid‐based human BMP‐2 construct (pCAGGS‐BMP‐2) and examined the induction of bone in the skeletal muscle of mice after plasmid transfer by transcutaneous sonoporation. First, an in vitro study was performed to confirm the expression of BMP‐2 after gene transfer by sonoporation using pCAGGS‐BMP‐2. Next, the BMP‐2 gene was transferred into the skeletal muscle of mice by transcutaneous sonoporation using pCAGGS‐BMP‐2. BMP‐2 production was assessed via immunohistochemistry, and osteoinduction was verified by radiography, histology and biochemical assays.

Results

The presence of human BMP‐2, alkaline phosphatase and osteocalcin mRNA and the production of the alkaline phosphatase were observed in vitro. Moreover, mature bone was observed in mice sonoporated with pCAGGS‐BMP‐2, confirming that transcutaneous sonoporation with pCAGGS‐BMP‐2 caused osteoinduction in the skeletal muscle of mice.

Conclusions

These results suggest the possibility of the effective clinical use of human BMP‐2 gene therapy using transcutaneous sonoporation, and should facilitate clinical applications of BMP‐2 gene therapy. Copyright © 2009 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Osteoinduction by repeat plasmid injecti
Osteoinduction by repeat plasmid injection of human bone morphogenetic protein-2
✍ Kenji Osawa; Yasunori Okubo; Kazumasa Nakao; Noriaki Koyama; Kazuhisa Bessho 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB

## Abstract ## Background Bone morphogenetic protein‐2 (BMP‐2) is an osteoinductive protein and is considered useful for the treatment of skeletal disorders. Previous studies using BMP‐2 in clinical applications have encountered difficulties, including the lack of an efficient, safe, inexpensive a

Immobilized recombinant human bone morph
Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphorylation of receptor-activated Smads
✍ Eiki Yamachika; Hidetsugu Tsujigiwa; Nobuaki Shirasu; Takaaki Ueno; Yoshirou Sak 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 404 KB

## Abstract Bone morphogenetic protein (BMP)‐2 plays an important role in bone growth and regeneration; however, BMP‐2 is easily lost by diffusion through body fluid and has some inhibitory pathways. To address this problem, we previously immobilized recombinant human BMP‐2 (rhBMP‐2) on succinylate

Up-regulation of bone morphogenetic prot
Up-regulation of bone morphogenetic protein receptor IB by growth factors enhances BMP-2-induced human bone cell functions
✍ Weerachai Singhatanadgit; Vehid Salih; Irwin Olsen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

## Abstract Bone morphogenetic proteins (BMP) stimulate osteoblast differentiation by signal transduction via three BMP receptors (BMPR‐IA, ‐IB, and ‐II). Several growth factors, including transforming growth factor‐β1 (TGF‐β1), fibroblast growth factor‐2 (FGF‐2) and platelet‐derived growth factor‐

Regulation of bone matrix protein expres
Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2
✍ Fernando Lecanda; Louis V. Avioli; Su-Li Cheng 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 592 KB

We have examined the effects of BMP-2 on the expression of bone matrix proteins in both human bone marrow stromal cells (HBMSC) and human osteoblasts (HOB) and their proliferation and mineralization. Both HBMSC and HOB express BMP-2/-4 type I and type II receptors. Treatment of these two cell types

Restoration of segmental bone defects in
Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2
✍ Mori, Masahiro ;Isobe, Masatsugu ;Yamazaki, Yasuharu ;Ishihara, Kazuhiko ;Nakaba 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Recombinant human bone morphogenetic protein-2 (rhBMP-2) was encapsulated in biodegradable poly(DL-lactide-co-glycolide) (PLGA) capsules to regenerate bone by controlling the release rate of rhBMP-2. The rhBMP-2/PLGA capsules containing 12 g of rhBMP-2 were implanted in seven 15-mm segmental defects

Regulation of bone morphogenetic protein
Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
✍ Toshitaka Arikawa; Ken Omura; Ikuo Morita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 2 views

## Abstract Cyclooxygenase (COX)‐2 is generally known as an inducible enzyme, and it produces arachidonic acid to prostaglandin E2 (PGE2), which modulates bone metabolism. Here, we investigated the expression and role of COX isomers in human mesenchymal stem cells. Human mesenchymal stem cells cons